Dosage:800mg

Size: 120 capsules.

Two capsules twice daily. Best taken on an empty stomach. Additional capsules may be taken as needed.

IP-6 (inositol hexaphosphate) 800mg.

Inositol hexaphosphate (IP-6) is a brown rice extract that improves natural killer cell activity and is absorbed by cancer cells, where it stops cell proliferation and restores normal function. We now know from various scientific studies, IP-6 has potential for cancer treatment and prevention.

Scientific Studies

AbulKalam M. Shamsuddin, MD, PhD., a professor of pathology at the University of Maryland School of Medicine in Baltimore, has written a book (Nature's Revolutionary Cancer-Fighter, Kensington Publishing Corp.) about his studies of IP-6. His research has shown that it can slow or stop the growth of liver cancer cells in the laboratory and in mice. Dr. Shamsuddin has reported that while IP-6 doesn't actually kill cancer cells, it makes them behave like normal cells, thus eliminating the danger they pose. A number of laboratory studies have confirmed his findings. Research suggests that IP-6 can boost immune function, help lower cholesterol, prevent formation of kidney stones, reduce the risk of heart disease and stroke, and prevent the complications of diabetes.

Inositol Phosphates Have Novel Anticancer Function Authors: Shamsuddin AM Source: J. Nutr. 1995; 125:725S-732S.

Inositol Phosphates with Different Numbers of Phosphate Groups Influence Iron Absorption in Humans Authors: Sandberg A-S, Brune M, Carlsson N-G, Hallberg L, Skoglund E, Rossander-Hulthen L Source: Am J Clin Nutr. 1999; 70:240-246.

Inositol-Phosphate-Induced Enhancement of Natural Killer Cell Activity Correlates with Tumor Suppression Authors: Baten A, Ullah A, Tomazic VJ, Shamsuddin AM Source: Carcinogenesis. 1989; 10(9):1595-1598.

IP6 in Treatment of Liver Cancer. I. IP6 Inhibits Growth and Reverses Transformed Phenotype in HepG2 Human Liver Cancer Cell Line. Authors: Vucenik I, Tantivejkul K, Zhang ZS, Cole KE, Saied I, Shamsuddin AM Source: Anticancer Res. 1998; 18(16A):4083-4090.

IP6 in Treatment of Liver Cancer II. Intra-Tumoral Injection of IP6 Regresses Pre-Existing Human Liver Cancer Xenotransplanted in Nude Mice. Authors: Vucenik I, Zhang ZS, Shamsuddin AM Source: Anticancer Res. 1998; 18(6A):4091-4096.

IP6-Induced Growth Inhibition and Differentiation of HT-29 Human Colon Cancer Cells: Involvement of Intracellular Inositol Phosphates Authors: Yang G, Shamsuddin AM Source: Anticancer Research. 1995; 15:2479-2488.

IP6: A Novel Anti-Cancer Agent Authors: Shamsuddin AM, Vucenik I, Cole KE Source: Life Sciences. 1997; 61(4):343-354.

Novel Anti-Cancer Functions of IP6: Growth Inhibition and Differentiation of Human Mammary Cancer Cell Lines in Vitro Authors: Shamsuddin AM, Yang GY, Vucenik I Source: Anticancer Research. 1996; 16:3287-3292.

Novel Anticancer Function of Inositol Hexaphosphate: Inhibition of Human Rhabdomyosarcoma in Vitro and in Vivo Authors: Vucenik I, Kalebic T, Tantivejkul K, Shamsuddin AM Source: Anticancer Research. 1998; 18:1377-1384.

Suppression of Large Intestinal Cancer in F344 Rats by Inositol Hexaphosphate Authors: Shamsuddin AM, Elsayed AM, Ullah A Source: Carcinogenesis. 1988; 9(4):577-580.

Up-Regulation of the Tumor Suppressor Gene p53 and WAF1 gene expression by IP6 in HT-29 Human Colon Carcinoma Cell Line Authors: Saied IT, Shamsuddin AM Source: Anticancer Res. 1998; 18(3A):1479-1484.

This is a statement of nutritional support. This statement has not been evaluated by the FDA. This product is not intended to medically diagnose, treat, cure, or prevent any disease. Always consult your health care provider before using any supplement.